A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility.

Peter A Kanetsky, Nandita Mitra, Saran Vardhanabhuti, David J Vaughn, Mingyao Li, Stephanie L Ciosek, Richard Letrero, Kurt D'Andrea, Madhavi Vaddi, David R Doody, Joellen Weaver, Chu Chen, Jacqueline R Starr, Håkon Håkonarson, Daniel J Rader, Andrew K Godwin, Muredach P Reilly, Stephen M Schwartz, Katherine L Nathanson
Author Information
  1. Peter A Kanetsky: Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. pkanetsk@mail.med.upenn.edu

Abstract

Susceptibility to testicular germ cell tumors (TGCT) has a significant heritable component, and genome-wide association studies (GWASs) have identified association with variants in several genes, including KITLG, SPRY4, BAK1, TERT, DMRT1 and ATF7IP. In our GWAS, we genotyped 349 TGCT cases and 919 controls and replicated top hits in an independent set of 439 cases and 960 controls in an attempt to find novel TGCT susceptibility loci. We identified a second marker (rs7040024) in the doublesex and mab-3-related transcription factor 1 (DMRT1) gene that is independent of the previously described risk allele (rs755383) at this locus. In combined analysis that mutually conditions on both DMRT1 single nucleotide polymorphism markers, TGCT cases had elevated odds of carriage of the rs7040024 major A allele [per-allele odds ratio (OR) = 1.48, 95% confidence interval (CI) 1.23, 1.78; P = 2.52 × 10(-5)] compared with controls, while the association with rs755383 persisted (per allele OR = 1.26, 95% CI 1.08, 1.47, P = 0.0036). In similar analyses, the association of rs7040024 among men with seminomatous tumors did not differ from that among men with non-seminomatous tumors. In combination with KITLG, the strongest TGCT susceptibility locus found to date, men with TGCT had greatly elevated odds (OR = 14.1, 95% CI 5.12, 38.6; P = 2.98 × 10(-7)) of being double homozygotes for the risk (major) alleles at DMRT (rs7040024) and KITLG (rs4474514) when compared with men without TGCT. Our findings continue to corroborate that genes influencing male germ cell development and differentiation have emerged as the major players in inherited TGCT susceptibility.

References

  1. Int J Cancer. 2009 Feb 15;124(4):952-7 [PMID: 19035442]
  2. J Am Coll Cardiol. 2007 Jan 30;49(4):442-9 [PMID: 17258089]
  3. Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2183-90 [PMID: 16172230]
  4. Cancer Genet Cytogenet. 2003 Jun;143(2):174-7 [PMID: 12781454]
  5. Nat Genet. 2009 Jul;41(7):811-5 [PMID: 19483682]
  6. Am J Hum Genet. 2007 Sep;81(3):559-75 [PMID: 17701901]
  7. J Natl Cancer Inst. 1994 Jul 20;86(14):1070-5 [PMID: 8021956]
  8. Nat Genet. 2009 Jul;41(7):807-10 [PMID: 19483681]
  9. Urology. 2001 Apr;57(4):747-52 [PMID: 11306395]
  10. Nat Genet. 2010 Jul;42(7):570-5 [PMID: 20562874]
  11. Cancer Res. 2004 Jul 15;64(14):4736-43 [PMID: 15256440]
  12. Mol Hum Reprod. 2004 Jun;10(6):423-31 [PMID: 15123780]
  13. Genes Dev. 2000 Oct 15;14(20):2587-95 [PMID: 11040213]
  14. Nat Genet. 2008 Oct;40(10):1166-74 [PMID: 18776908]
  15. Eur J Cancer. 1999 Sep;35(9):1368-73 [PMID: 10658529]
  16. Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1316-24 [PMID: 15298952]
  17. Genomics. 2000 May 1;65(3):203-12 [PMID: 10857744]
  18. Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22323-8 [PMID: 20007774]
  19. Epidemiology. 1992 Sep;3(5):452-6 [PMID: 1391139]
  20. Int J Cancer. 2002 May 10;99(2):260-6 [PMID: 11979442]
  21. APMIS. 2003 Jan;111(1):267-78; discussion 278-9 [PMID: 12752272]
  22. Br J Cancer. 1996 Apr;73(7):964-9 [PMID: 8611416]
  23. Dev Biol. 2007 Jul 15;307(2):314-27 [PMID: 17540358]
  24. Nat Genet. 2010 Jul;42(7):604-7 [PMID: 20543847]
  25. Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2557-62 [PMID: 16284378]
  26. Mol Cell Endocrinol. 2008 Sep 10;291(1-2):1-10 [PMID: 18403106]
  27. J Natl Cancer Inst. 2004 Jan 21;96(2):145-7 [PMID: 14734704]
  28. Genet Epidemiol. 2009 May;33(4):290-8 [PMID: 19051284]
  29. Br J Cancer. 2008 Jan 15;98(1):171-3 [PMID: 18071360]
  30. Genet Epidemiol. 2010 Dec;34(8):816-34 [PMID: 21058334]
  31. Sex Dev. 2007;1(1):42-58 [PMID: 18391515]
  32. Trends Genet. 2009 Nov;25(11):479-81 [PMID: 19819582]
  33. Nat Genet. 2006 Feb;38(2):209-13 [PMID: 16415888]
  34. Ann Intern Med. 2010 Sep 21;153(6):396-9 [PMID: 20855803]
  35. Annu Rev Genomics Hum Genet. 2009;10:387-406 [PMID: 19715440]
  36. Br J Cancer. 1999 Jun;80(7):1098-102 [PMID: 10362123]
  37. Br J Cancer. 1992 Feb;65(2):255-62 [PMID: 1739626]
  38. APMIS. 1998 Jan;106(1):64-70; discussion 71-2 [PMID: 9524563]
  39. Arch Intern Med. 2009 Feb 23;169(4):351-6 [PMID: 19237718]
  40. PLoS One. 2009;4(5):e5591 [PMID: 19440348]
  41. J Urol. 2003 Jul;170(1):5-11 [PMID: 12796635]
  42. Nature. 2007 Jun 7;447(7145):661-78 [PMID: 17554300]
  43. Int J Androl. 2006 Feb;29(1):205-10 [PMID: 16466541]
  44. Ann Intern Med. 2011 Apr 5;154(7):483-6 [PMID: 21464350]
  45. Pathol Oncol Res. 2004;10(4):197-203 [PMID: 15619639]
  46. Nat Genet. 2007 Jul;39(7):906-13 [PMID: 17572673]
  47. Int J Cancer. 1996 May 29;66(5):627-31 [PMID: 8647624]
  48. Am J Hum Genet. 2000 Jun;66(6):1933-44 [PMID: 10801388]
  49. Cancer Causes Control. 2005 Aug;16(6):651-6 [PMID: 16049803]

Grants

  1. R01 CA114478/NCI NIH HHS
  2. R01CA085914/NCI NIH HHS
  3. P30 CA006927/NCI NIH HHS
  4. R01CA114478/NCI NIH HHS
  5. CA093283/NCI NIH HHS
  6. 5P30CA016520/NCI NIH HHS

MeSH Term

Adolescent
Adult
Genome-Wide Association Study
Genotype
Humans
Male
Neoplasms, Germ Cell and Embryonal
Testicular Neoplasms
Transcription Factors
Young Adult

Chemicals

DMRT1 protein
Transcription Factors

Word Cloud

Created with Highcharts 10.0.0TGCT1=associationDMRT1susceptibilityrs7040024mengermcelltumorsKITLGcasescontrolsindependentallelelocusoddsmajorOR95%CIPtesticularidentifiedgenessecondriskrs755383elevated2×10comparedamongSusceptibilitysignificantheritablecomponentgenome-widestudiesGWASsvariantsseveralincludingSPRY4BAK1TERTATF7IPGWASgenotyped349919replicatedtophitsset439960attemptfindnovellocimarkerdoublesexmab-3-relatedtranscriptionfactorgenepreviouslydescribedcombinedanalysismutuallyconditionssinglenucleotidepolymorphismmarkerscarriage[per-alleleratio48confidenceinterval237852-5]persistedper26084700036similaranalysesseminomatousdiffernon-seminomatouscombinationstrongestfounddategreatly1451238698-7doublehomozygotesallelesDMRTrs4474514withoutfindingscontinuecorroborateinfluencingmaledevelopmentdifferentiationemergedplayersinheritedwithinassociatedtumor

Similar Articles

Cited By